Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05751837 · ClinicalTrials.gov registry record · Phase 1
Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal
A Phase 1 study of Malignancy and Abdominal Cancer, sponsored by Patrick Wagner, MD, FACS.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT05751837 is a Phase 1 study of Malignancy and Abdominal Cancer that has completed, run by Patrick Wagner, MD, FACS. The registered enrollment target is 10 participants, below the 12,586-participant average among 8 other Malignancy trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05751837, a Phase 1 study of Malignancy and Abdominal Cancer, has completed, sponsored by Patrick Wagner, MD, FACS.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to determine whether a sterile bacteria wall chemical, called lipopolysaccharide (LPS), can be injected safely into abdominal tumors during routine laparoscopic surgery performed as a preliminary procedure in patients who will subsequently undergo a larger planned operation to remove abdominal tumors. The researchers will biopsy the tumor before injection and then again at the time of the larger operation to assess whether any effect of the treatment can be measured.
Conditions Studied
Interventions
- BIOLOGICAL Lipopolysaccharide
Study Locations (2)
Pennsylvania
- Allegheny Health Network Allegheny General Hospital - Pittsburgh
- Allegheny Health Network West Penn Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-03-16 |
| Est. Completion | 2024-05-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05751837
The ClinicalTrials.gov registry entry for NCT05751837 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,586-participant average among 8 other Malignancy trials with a reported enrollment target (100% lower). The listed sponsor is Patrick Wagner, MD, FACS, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Malignancy appearing as the primary indexed condition, and to 1 intervention - of which Lipopolysaccharide is the first listed.
NCT05751837 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05751837 about?
NCT05751837 is a clinical study titled "Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal". The purpose of this research study is to determine whether a sterile bacteria wall chemical, called lipopolysaccharide (LPS), can be injected safely into abdominal tumors during routine laparoscopic surgery performed as a preliminary procedure in patients who will subsequently undergo a larger plann...
What is the current status of trial NCT05751837?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2023-03-16. Estimated completion is 2024-05-30.
What conditions does trial NCT05751837 study?
This clinical trial studies the following conditions: Malignancy, Abdominal Cancer.
What interventions are being tested in trial NCT05751837?
The interventions under investigation include: Lipopolysaccharide (BIOLOGICAL).
Who is sponsoring clinical trial NCT05751837?
This trial is sponsored by Patrick Wagner, MD, FACS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05751837 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
RECRUITING · Phase 1
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
BostonGene-Integrated Genomic Registry (BIGR)
RECRUITING
-
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
RECRUITING
-
Immuno-Oncology Database and Bioregistry
ACTIVE NOT RECRUITING
-
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.